Prodia Widyahusada Tbk PT
IDX:PRDA
Prodia Widyahusada Tbk PT
IDX:PRDA
Price:
2 690
IDR
-0.37%
Market Closed
Market Cap:
2.5T
IDR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
PRDA Alert
Prodia Widyahusada Tbk PT
2690
-10 (-0.37%)
| 52 Week Range |
2 610
5 450
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Prodia Widyahusada Tbk PT
Income Statement
Earnings Waterfall
Prodia Widyahusada Tbk PT
Prodia Widyahusada Tbk PT
|
Revenue
|
2.2T
IDR
|
|
Cost of Revenue
|
-907.7B
IDR
|
|
Gross Profit
|
1.3T
IDR
|
|
Operating Expenses
|
-1.1T
IDR
|
|
Operating Income
|
246.8B
IDR
|
|
Other Expenses
|
-28.2B
IDR
|
|
Net Income
|
218.6B
IDR
|
Income Statement
Prodia Widyahusada Tbk PT
Prodia Widyahusada Tbk PT
Currency: IDR
| Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||
| Revenue |
1 466 017
N/A
|
1 490 887
+2%
|
1 505 996
+1%
|
1 540 927
+2%
|
1 599 757
+4%
|
1 642 794
+3%
|
1 686 253
+3%
|
1 721 952
+2%
|
1 744 271
+1%
|
1 736 170
0%
|
1 602 474
-8%
|
1 707 456
+7%
|
1 873 375
+10%
|
2 107 532
+12%
|
2 454 438
+16%
|
2 661 941
+8%
|
2 652 257
0%
|
2 582 797
-3%
|
2 450 910
-5%
|
2 241 607
-9%
|
2 181 642
-3%
|
2 143 398
-2%
|
2 207 703
+3%
|
2 214 011
+0%
|
2 222 466
+0%
|
2 191 490
-1%
|
2 191 679
+0%
|
2 208 542
+1%
|
|
| Gross Profit | |||||||||||||||||||||||||||||
| Cost of Revenue |
(612 487)
|
(626 121)
|
(634 515)
|
(643 581)
|
(656 946)
|
(667 152)
|
(679 180)
|
(702 863)
|
(703 260)
|
(707 280)
|
(692 399)
|
(734 179)
|
(827 152)
|
(895 382)
|
(979 115)
|
(1 037 354)
|
(1 019 556)
|
(1 007 549)
|
(957 967)
|
(880 273)
|
(854 535)
|
(840 514)
|
(859 590)
|
(870 052)
|
(903 247)
|
(894 688)
|
(901 709)
|
(907 685)
|
|
| Gross Profit |
853 530
N/A
|
864 766
+1%
|
871 481
+1%
|
897 346
+3%
|
942 811
+5%
|
975 642
+3%
|
1 007 073
+3%
|
1 019 089
+1%
|
1 041 011
+2%
|
1 028 890
-1%
|
910 075
-12%
|
973 277
+7%
|
1 046 223
+7%
|
1 212 150
+16%
|
1 475 323
+22%
|
1 624 587
+10%
|
1 632 701
+0%
|
1 575 248
-4%
|
1 492 943
-5%
|
1 361 334
-9%
|
1 327 107
-3%
|
1 302 884
-2%
|
1 348 113
+3%
|
1 343 959
0%
|
1 319 219
-2%
|
1 296 802
-2%
|
1 289 970
-1%
|
1 300 857
+1%
|
|
| Operating Income | |||||||||||||||||||||||||||||
| Operating Expenses |
(704 124)
|
(728 413)
|
(717 279)
|
(733 242)
|
(759 159)
|
(772 826)
|
(799 435)
|
(823 073)
|
(823 110)
|
(830 148)
|
(805 170)
|
(744 140)
|
(744 528)
|
(746 297)
|
(770 969)
|
(820 064)
|
(874 587)
|
(886 869)
|
(913 581)
|
(902 839)
|
(883 120)
|
(901 386)
|
(919 935)
|
(950 892)
|
(1 013 335)
|
(1 033 281)
|
(1 029 921)
|
(1 054 091)
|
|
| Selling, General & Administrative |
(661 406)
|
(670 977)
|
(665 075)
|
(680 165)
|
(705 681)
|
(715 336)
|
(740 823)
|
(761 688)
|
(758 709)
|
(752 549)
|
(715 372)
|
(640 624)
|
(627 803)
|
(630 011)
|
(651 111)
|
(699 348)
|
(750 159)
|
(761 453)
|
(788 218)
|
(773 347)
|
(761 926)
|
(780 554)
|
(800 814)
|
(829 752)
|
(882 347)
|
(888 904)
|
(879 843)
|
(901 296)
|
|
| Research & Development |
(3 833)
|
(4 029)
|
(4 197)
|
(4 658)
|
(2 546)
|
(2 274)
|
(2 269)
|
(1 937)
|
(1 566)
|
(1 655)
|
(1 561)
|
(1 361)
|
(1 243)
|
(784)
|
(1 167)
|
(1 553)
|
(2 050)
|
(2 351)
|
(2 956)
|
(3 433)
|
(3 119)
|
(3 483)
|
(2 346)
|
(1 742)
|
(1 849)
|
(2 731)
|
(4 006)
|
(5 062)
|
|
| Depreciation & Amortization |
(47 449)
|
(51 910)
|
(57 231)
|
(60 060)
|
(62 198)
|
(68 277)
|
(67 773)
|
(68 590)
|
(67 128)
|
(77 678)
|
(92 910)
|
(106 331)
|
(116 715)
|
(118 869)
|
(119 830)
|
(120 715)
|
(123 897)
|
(123 977)
|
(123 563)
|
(127 818)
|
(125 086)
|
(125 543)
|
(126 289)
|
(130 515)
|
(136 101)
|
(147 879)
|
(151 993)
|
(155 122)
|
|
| Other Operating Expenses |
8 564
|
(1 497)
|
9 223
|
11 641
|
11 266
|
13 061
|
11 430
|
9 142
|
4 293
|
1 734
|
4 673
|
4 176
|
1 233
|
3 367
|
1 139
|
1 552
|
1 519
|
912
|
1 156
|
1 759
|
7 011
|
8 194
|
9 514
|
11 117
|
6 962
|
6 233
|
5 921
|
7 389
|
|
| Operating Income |
149 406
N/A
|
136 354
-9%
|
154 202
+13%
|
164 104
+6%
|
183 652
+12%
|
202 816
+10%
|
207 638
+2%
|
196 016
-6%
|
217 901
+11%
|
198 742
-9%
|
104 905
-47%
|
229 137
+118%
|
301 695
+32%
|
465 853
+54%
|
704 354
+51%
|
804 523
+14%
|
758 114
-6%
|
688 379
-9%
|
579 362
-16%
|
458 495
-21%
|
443 987
-3%
|
401 498
-10%
|
428 178
+7%
|
393 067
-8%
|
305 884
-22%
|
263 521
-14%
|
260 049
-1%
|
246 766
-5%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||
| Interest Income Expense |
46 878
|
60 390
|
45 278
|
43 488
|
38 469
|
39 040
|
41 481
|
44 007
|
48 711
|
49 456
|
44 190
|
37 845
|
37 385
|
33 481
|
32 957
|
33 407
|
30 052
|
29 348
|
26 839
|
26 954
|
25 507
|
25 789
|
28 687
|
28 287
|
31 724
|
33 344
|
35 301
|
38 641
|
|
| Non-Reccuring Items |
430
|
485
|
386
|
354
|
(428)
|
(627)
|
(674)
|
(612)
|
(1 812)
|
(1 321)
|
(1 336)
|
(1 824)
|
(2)
|
(316)
|
(278)
|
939
|
469
|
496
|
471
|
137
|
853
|
935
|
1 060
|
1 273
|
1 294
|
1 380
|
1 667
|
1 393
|
|
| Total Other Income |
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
196 714
N/A
|
197 228
+0%
|
199 866
+1%
|
207 946
+4%
|
221 693
+7%
|
241 230
+9%
|
248 445
+3%
|
239 411
-4%
|
264 800
+11%
|
246 877
-7%
|
147 759
-40%
|
265 158
+79%
|
339 078
+28%
|
499 018
+47%
|
737 033
+48%
|
838 869
+14%
|
788 635
-6%
|
718 223
-9%
|
606 672
-16%
|
485 586
-20%
|
470 347
-3%
|
428 222
-9%
|
457 926
+7%
|
422 627
-8%
|
338 902
-20%
|
298 245
-12%
|
297 016
0%
|
286 800
-3%
|
|
| Net Income | |||||||||||||||||||||||||||||
| Tax Provision |
(45 917)
|
(46 234)
|
(46 958)
|
(49 564)
|
(46 243)
|
(50 328)
|
(52 163)
|
(49 485)
|
(54 539)
|
(49 794)
|
(31 282)
|
(53 589)
|
(70 331)
|
(106 303)
|
(155 168)
|
(181 313)
|
(165 405)
|
(150 122)
|
(126 280)
|
(99 856)
|
(98 721)
|
(90 443)
|
(97 414)
|
(90 694)
|
(79 578)
|
(71 331)
|
(70 850)
|
(68 809)
|
|
| Income from Continuing Operations |
150 797
|
150 994
|
152 908
|
158 382
|
175 450
|
190 902
|
196 282
|
189 926
|
210 261
|
197 083
|
116 477
|
211 569
|
268 747
|
392 715
|
581 865
|
657 556
|
623 230
|
568 101
|
480 392
|
385 730
|
371 626
|
337 779
|
360 512
|
331 933
|
259 324
|
226 914
|
226 166
|
217 991
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
21
|
68
|
120
|
183
|
550
|
583
|
605
|
602
|
|
| Net Income (Common) |
150 797
N/A
|
150 994
+0%
|
152 909
+1%
|
158 382
+4%
|
175 450
+11%
|
190 902
+9%
|
196 281
+3%
|
189 926
-3%
|
210 261
+11%
|
197 083
-6%
|
116 477
-41%
|
211 569
+82%
|
268 747
+27%
|
392 715
+46%
|
581 865
+48%
|
657 556
+13%
|
623 230
-5%
|
568 101
-9%
|
480 392
-15%
|
385 740
-20%
|
371 647
-4%
|
337 847
-9%
|
360 632
+7%
|
332 116
-8%
|
259 874
-22%
|
227 497
-12%
|
226 771
0%
|
218 593
-4%
|
|
| EPS (Diluted) |
160.85
N/A
|
160.97
+0%
|
163.01
+1%
|
168.94
+4%
|
187.14
+11%
|
203.63
+9%
|
209.37
+3%
|
202.59
-3%
|
224.27
+11%
|
210.22
-6%
|
124.24
-41%
|
225.67
+82%
|
286.66
+27%
|
418.9
+46%
|
620.66
+48%
|
701.39
+13%
|
659.01
-6%
|
600.73
-9%
|
507.96
-15%
|
407.88
-20%
|
394.87
-3%
|
358.95
-9%
|
384.67
+7%
|
354.25
-8%
|
277.19
-22%
|
242.66
-12%
|
241.89
0%
|
233.17
-4%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
